This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​Drug supply to NHS draws new UK antitrust probe (update*)

By Matthew Newman and Lewis Crofts ( October 25, 2016, 15:08 GMT | Insight) -- Supplies of pharmaceuticals to the UK’s National Health Service fell under antitrust scrutiny today, as the Competition and Markets Authority opened a new investigation. The CMA didn’t specify which drug was at issue or which company was targeted, but Canadian producer Concordia International has confirmed that it is under investigation.*Supplies of pharmaceuticals to the UK’s National Health Service fell under antitrust scrutiny today, as the Competition and Markets Authority opened a new investigation....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections